|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wakamatsu Y, Sakamoto N, Oo HZ, Naito Y,
Uraoka N, Anami K, Sentani K, Oue N and Yasui W: Expression of
cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and
lymph node metastasis of gastric cancer. Pathol Int. 62:112–119.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hsu KW, Hsieh RH, Huang KH, Fen-Yau Li A,
Chi CW, Wang TY, Tseng MJ, Wu KJ and Yeh TS: Activation of the
Notch1/STAT3/Twist signaling axis promotes gastric cancer
progression. Carcinogenesis. 33:1459–1467. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Takano Y, Kato Y, Masuda M, Ohshima Y and
Okayasu I: Cyclin D2, but not cyclin D1, overexpression closely
correlates with gastric cancer progression and prognosis. J Pathol.
189:194–200. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Maruyama K, Gunvén P, Okabayashi K, Sasako
M and Kinoshita T: Lymph node metastases of gastric cancer. General
pattern in 1931 patients. Ann Surg. 210:596–602. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Qu JL, Qu XJ, Zhao MF, Teng YE, Zhang Y,
Hou KZ, Jiang YH, Yang XH and Liu YP: Gastric cancer exosomes
promote tumour cell proliferation through PI3K/Akt and MAPK/ERK
activation. Dig Liver Dis. 41:875–880. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mulholland DJ, Kobayashi N, Ruscetti M,
Zhi A, Tran LM, Huang J, Gleave M and Wu H: Pten loss and RAS/MAPK
activation cooperate to promote EMT and metastasis initiated from
prostate cancer stem/progenitor cells. Cancer Res. 72:1878–1889.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Davis RJ: Signal transduction by the JNK
group of MAP kinases. Cell. 103:239–252. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Thompson NA, Haefliger JA, Senn A,
Tawadros T, Magara F, Ledermann B, Nicod P and Waeber G:
Islet-brain1/JNK-interacting protein-1 is required for early
embryogenesis in mice. J Biol Chem. 276:27745–27748. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Crew KD and Neugut AI: Epidemiology of
gastric cancer. World J Gastroenterol. 12:354–362. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cao M, Seike M, Soeno C, Mizutani H,
Kitamura K, Minegishi Y, Noro R, Yoshimura A, Cai L and Gemma A:
MiR-23a regulates TGF-β-induced epithelial-mesenchymal transition
by targeting E-cadherin in lung cancer cells. Int J Oncol.
41:869–875. 2012.PubMed/NCBI
|
|
14
|
Pacurari M, Addison JB, Bondalapati N, Wan
YW, Luo D, Qian Y, Castranova V, Ivanov AV and Guo NL: The
microRNA-200 family targets multiple non-small cell lung cancer
prognostic markers in H1299 cells and BEAS-2B cells. Int J Oncol.
43:548–560. 2013.PubMed/NCBI
|
|
15
|
Verdoodt B, Neid M, Vogt M, Kuhn V,
Liffers ST, Palisaar RJ, Noldus J, Tannapfel A and
Mirmohammadsadegh A: MicroRNA-205, a novel regulator of the
anti-apoptotic protein Bcl2, is downregulated in prostate cancer.
Int J Oncol. 43:307–314. 2013.PubMed/NCBI
|
|
16
|
Wang P, Zou F, Zhang X, Li H, Dulak A,
Tomko RJ Jr, Lazo JS, Wang Z, Zhang L and Yu J: microRNA-21
negatively regulates Cdc25A and cell cycle progression in colon
cancer cells. Cancer Res. 69:8157–8165. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Calin GA, Ferracin M, Cimmino A, Di Leva
G, Shimizu M, Wojcik SE, Iorio MV, Visone R, Sever NI, Fabbri M, et
al: A MicroRNA signature associated with prognosis and progression
in chronic lymphocytic leukemia. N Engl J Med. 353:1793–1801. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Veerla S, Lindgren D, Kvist A, Frigyesi A,
Staaf J, Persson H, Liedberg F, Chebil G, Gudjonsson S, Borg A, et
al: MiRNA expression in urothelial carcinomas: Important roles of
miR-10a, miR-222, miR-125b, miR-7 and miR-452 for tumor stage and
metastasis, and frequent homozygous losses of miR-31. Int J Cancer.
124:2236–2242. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ujifuku K, Mitsutake N, Takakura S,
Matsuse M, Saenko V, Suzuki K, Hayashi K, Matsuo T, Kamada K,
Nagata I and Yamashita S: miR-195, miR-455-3p and miR-10a (*) are
implicated in acquired temozolomide resistance in glioblastoma
multiforme cells. Cancer Lett. 296:241–248. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ohuchida K, Mizumoto K, Lin C, Yamaguchi
H, Ohtsuka T, Sato N, Toma H, Nakamura M, Nagai E, Hashizume M and
Tanaka M: MicroRNA-10a is overexpressed in human pancreatic cancer
and involved in its invasiveness partially via suppression of the
HOXA1 gene. Ann Surg Oncol. 19:2394–2402. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Weiss FU, Marques IJ, Woltering JM,
Vlecken DH, Aghdassi A, Partecke LI, Heidecke CD, Lerch MM and
Bagowski CP: Retinoic acid receptor antagonists inhibit miR-10a
expression and block metastatic behavior of pancreatic cancer.
Gastroenterology. 137:2136–2145.e1-7. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ma L, Reinhardt F, Pan E, Soutschek J,
Bhat B, Marcusson EG, Teruya-Feldstein J, Bell GW and Weinberg RA:
Therapeutic silencing of miR-10b inhibits metastasis in a mouse
mammary tumor model. Nat Biotechnol. 28:341–347. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen W, Tang Z, Sun Y, Zhang Y, Wang X,
Shen Z, Liu F and Qin X: miRNA expression profile in primary
gastric cancers and paired lymph node metastases indicates that
miR-10a plays a role in metastasis from primary gastric cancer to
lymph nodes. Exp Ther Med. 3:351–356. 2012.PubMed/NCBI
|
|
24
|
Novák J and Fabian P: Comments on the TNM
classification of malignant tumours - 7th edition. Klin Onkol.
24:149–150. 2011.(In Czech). PubMed/NCBI
|
|
25
|
Brabletz T, Jung A, Spaderna S, Hlubek F
and Kirchner T: Opinion: migrating cancer stem cells - an
integrated concept of malignant tumour progression. Nat Rev Cancer.
5:744–749. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu J, Zhang Y, Xu R, Du J, Hu Z, Yang L,
Chen Y, Zhu Y and Gu L: PI3K/Akt-dependent phosphorylation of GSK3β
and activation of RhoA regulate Wnt5a-induced gastric cancer cell
migration. Cell Signal. 25:447–456. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang Z, Liu S, Shi R and Zhao G: miR-27
promotes human gastric cancer cell metastasis by inducing
epithelial-to-mesenchymal transition. Cancer Genet. 204:486–491.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li X, Zhang Y, Zhang H, Liu X, Gong T, Li
M, Sun L, Ji G, Shi Y, Han Z, et al: miRNA-223 promotes gastric
cancer invasion and metastasis by targeting tumor suppressor
EPB41L3. Mol Cancer Res. 9:824–833. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cai L, Li J, Zhang X, Lu Y, Wang J, Lyu X,
Chen Y, Liu J, Cai H, Wang Y and Li X: Gold nano-particles (AuNPs)
carrying anti-EBV-miR-BART7-3p inhibit growth of EBV-positive
nasopharyngeal carcinoma. Oncotarget. 6:7838–7850. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Doll R and Peto R: The causes of cancer:
Quantitative estimates of avoidable risks of cancer in the United
States today. J Natl Cancer Inst. 66:1191–1308. 1981.PubMed/NCBI
|
|
31
|
Harding TC, Xue L, Bienemann A, Haywood D,
Dickens M, Tolkovsky AM and Uney JB: Inhibition of JNK by
overexpression of the JNL binding domain of MAPK8IP1 prevents
apoptosis in sympathetic neurons. J Biol Chem. 276:4531–4534. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Saunders MA, Liang H and Li WH: Human
polymorphism at microRNAs and microRNA target sites. Proc Natl Acad
Sci USA. 104:3300–3305. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li D, Qu X, Hou K, Zhang Y, Dong Q, Teng
Y, Zhang J and Liu Y: PI3K/Akt is involved in bufalin-induced
apoptosis in gastric cancer cells. Anticancer Drugs. 20:59–64.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xie X, Tang B, Zhou J, Gao Q and Zhang P:
Inhibition of the PI3K/Akt pathway increases the chemosensitivity
of gastric cancer to vincristine. Oncol Rep. 30:773–782.
2013.PubMed/NCBI
|
|
35
|
Liu J, Liu Q, Wan Y, Zhao Z, Yu H, Luo H
and Tang Z: Osteopontin promotes the progression of gastric cancer
through the NF-κB pathway regulated by the MAPK and PI3K. Int J
Oncol. 45:282–290. 2014.PubMed/NCBI
|
